ESRRA | Estrogen-related receptor alpha | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
HNF4A | Hepatocyte nuclear factor 4, alpha | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
NR0B1 | Nuclear receptor subfamily 0, group B, member 1 | Cancer-related genes Disease related genes Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
NR2C1 | Nuclear receptor subfamily 2, group C, member 1 | Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR2C2 | Nuclear receptor subfamily 2, group C, member 2 | Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR2E1 | Nuclear receptor subfamily 2, group E, member 1 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
NR3C1 | Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR4A1 | Nuclear receptor subfamily 4, group A, member 1 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR4A2 | Nuclear receptor subfamily 4, group A, member 2 | Cancer-related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NR6A1 | Nuclear receptor subfamily 6, group A, member 1 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
PPARG | Peroxisome proliferator-activated receptor gamma | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
RARA | Retinoic acid receptor, alpha | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
RARB | Retinoic acid receptor, beta | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Mixed |
RARG | Retinoic acid receptor, gamma | Cancer-related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
RORC | RAR-related orphan receptor C | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Mixed |
RXRA | Retinoid X receptor, alpha | Cancer-related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
RXRB | Retinoid X receptor, beta | Cancer-related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
THRA | Thyroid hormone receptor, alpha | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
THRB | Thyroid hormone receptor, beta | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
VDR | Vitamin D (1,25- dihydroxyvitamin D3) receptor | Disease related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |